Common Contracts
6 similar Executive Employment Agreement contracts by Neoleukin Therapeutics, Inc., Prelude Therapeutics Inc
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 15th, 2024 • Prelude Therapeutics Inc • Pharmaceutical preparations • Delaware
This Executive Employment Agreement (the “Agreement”), made between Prelude Therapeutics Incorporated, a Delaware corporation (the “Company”), and Bryant Lim (“Executive” and, collectively with the Company, the “Parties”), is entered into as of January 30, 2023.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 8th, 2023 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington
This Executive Employment Agreement (the “Agreement”), made between Neoleukin Therapeutics, Inc., a Delaware corporation (the “Company”), and Sean Smith (the “Executive” and, collectively with the Company, the “Parties”), is entered into as of August 3, 2022 (the “Effective Date”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 20th, 2023 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington
This Executive Employment Agreement (the “Agreement”), made between Neoleukin Therapeutics, Inc., a Delaware corporation (the “Company”), and Donna Cochener (the “Executive” and, collectively with the Company, the “Parties”), is entered into as of March 4, 2022, to be effective as of the Effective Date (as defined below).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 1st, 2022 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington
This Executive Employment Agreement (the “Agreement”), made between Neoleukin Therapeutics, Inc., a Delaware corporation (the “Company”), and Priti Patel (the “Executive” and, collectively with the Company, the “Parties”), is entered into as of April 14, 2021, to be effective as of the Effective Date (as defined below).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 25th, 2021 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington
This Executive Employment Agreement (the “Agreement”), made between Neoleukin Therapeutics, Inc., a Delaware corporation (the “Company”), and Holly Vance (the “Executive” and, collectively with the Company, the “Parties”), is entered into as of September 29, 2020, to be effective as of the Effective Date (as defined below).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 6th, 2020 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington
This Executive Employment Agreement (the “Agreement”), made between Neoleukin Therapeutics, Inc. a Delaware corporation (the “Company”), and Robert Ho (“Executive” and, collectively with the Company, the “Parties”), is entered into as of March 16, 2020, to be effective as of the Effective Date (as defined below).
